175 related articles for article (PubMed ID: 25457818)
21. Brain volumetry in Parkinson's disease with and without dementia: where are the differences?
Lee SH; Kim SS; Tae WS; Lee SY; Lee KU; Jhoo J
Acta Radiol; 2013 Jun; 54(5):581-6. PubMed ID: 23474765
[TBL] [Abstract][Full Text] [Related]
22. Does a volume reduction of the parietal lobe contribute to freezing of gait in Parkinson's disease?
Rubino A; Assogna F; Piras F; Di Battista ME; Imperiale F; Chiapponi C; Spalletta G; Meco G
Parkinsonism Relat Disord; 2014 Oct; 20(10):1101-3. PubMed ID: 25112926
[TBL] [Abstract][Full Text] [Related]
23. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.
Lyoo CH; Ryu YH; Lee MS
Mov Disord; 2010 Mar; 25(4):496-9. PubMed ID: 20108369
[TBL] [Abstract][Full Text] [Related]
24. MRI and cognitive impairment in Parkinson's disease.
Ibarretxe-Bilbao N; Tolosa E; Junque C; Marti MJ
Mov Disord; 2009; 24 Suppl 2():S748-53. PubMed ID: 19877242
[TBL] [Abstract][Full Text] [Related]
25. Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease.
Ibarretxe-Bilbao N; Junque C; Marti MJ; Tolosa E
J Neurol Sci; 2011 Nov; 310(1-2):70-4. PubMed ID: 21864849
[TBL] [Abstract][Full Text] [Related]
26. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.
Hu MT; White SJ; Chaudhuri KR; Morris RG; Bydder GM; Brooks DJ
J Neural Transm (Vienna); 2001; 108(5):571-80. PubMed ID: 11459077
[TBL] [Abstract][Full Text] [Related]
27. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
28. Anterior temporal atrophy and posterior progression in patients with Parkinson's disease.
Potgieser AR; van der Hoorn A; Meppelink AM; Teune LK; Koerts J; de Jong BM
Neurodegener Dis; 2014; 14(3):125-32. PubMed ID: 25138823
[TBL] [Abstract][Full Text] [Related]
29. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
30. Psychometric limitations of the mini-mental state examination among nondemented older adults: an evaluation of neurocognitive and magnetic resonance imaging correlates.
Spencer RJ; Wendell CR; Giggey PP; Katzel LI; Lefkowitz DM; Siegel EL; Waldstein SR
Exp Aging Res; 2013; 39(4):382-97. PubMed ID: 23875837
[TBL] [Abstract][Full Text] [Related]
31. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
[TBL] [Abstract][Full Text] [Related]
32. Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease.
Gerrits NJ; van Loenhoud AC; van den Berg SF; Berendse HW; Foncke EM; Klein M; Stoffers D; van der Werf YD; van den Heuvel OA
PLoS One; 2016; 11(2):e0148852. PubMed ID: 26919667
[TBL] [Abstract][Full Text] [Related]
33. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
34. A comparison between the MoCA and the MMSE visuoexecutive sub-tests in detecting abnormalities in TIA/stroke patients.
Mai LM; Sposato LA; Rothwell PM; Hachinski V; Pendlebury ST
Int J Stroke; 2016 Jun; 11(4):420-4. PubMed ID: 26865154
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease.
Caviness JN; Hentz JG; Belden CM; Shill HA; Driver-Dunckley ED; Sabbagh MN; Powell JJ; Adler CH
J Parkinsons Dis; 2015; 5(1):117-24. PubMed ID: 25420672
[TBL] [Abstract][Full Text] [Related]
36. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
[TBL] [Abstract][Full Text] [Related]
37. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
[TBL] [Abstract][Full Text] [Related]
38. Initial cognitive decline is associated with cortical thinning in early Parkinson disease.
Pereira JB; Svenningsson P; Weintraub D; Brønnick K; Lebedev A; Westman E; Aarsland D
Neurology; 2014 Jun; 82(22):2017-25. PubMed ID: 24808018
[TBL] [Abstract][Full Text] [Related]
39. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
Bertrand JA; Bedetti C; Postuma RB; Monchi O; Génier Marchand D; Jubault T; Gagnon JF
Mov Disord; 2012 Dec; 27(14):1781-8. PubMed ID: 23147270
[TBL] [Abstract][Full Text] [Related]
40. [Influence of leukoaraiosis on the cognition of patients with Parkinson disease].
Wang L; Zhu XQ; Jiang CJ; Chen XW; Sun ZW
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):177-81. PubMed ID: 23570589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
